Is Alpine Immune Sciences, Inc. (ALPN) a Buy, Sell, or Hold?
NASDAQ : ALPN
Alpine Immune Sciences, Inc. — Stock Grades
$64.97 USD
$0.01 (0.02%)
- Volume
- 4.29M
- Average Volume
- 2.46M
- Market Capitalization
- $4.46B
- P/E Ratio
- -101.52
- Dividend Yield
- 0.00%
- Price Target
- $55.00
- Year High
- $65.00
- Year Low
- $8.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.86
ALPN Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2024-05-16 | Wedbush | Neutral | Neutral | Maintain |
| 2024-04-16 | TD Cowen | Buy | Hold | Downgrade |
| 2024-04-12 | Leerink Partners | Outperform | Market Perform | Downgrade |
| 2024-04-11 | Morgan Stanley | Overweight | Equal Weight | Downgrade |
| 2024-04-11 | Wedbush | Outperform | Neutral | Downgrade |
| 2024-04-11 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2024-04-11 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2024-03-21 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2024-03-19 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2024-03-19 | Wedbush | Outperform | Outperform | Maintain |
| 2024-03-19 | Oppenheimer | Outperform | Outperform | Maintain |
| 2024-03-19 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2024-03-12 | RBC Capital | Outperform | Outperform | Maintain |
| 2024-01-26 | Wedbush | Outperform | Outperform | Maintain |